George Roebuck
Optometrist · Morris, ILNPI 1720094287
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Optos, Inc. at 27.6% of the total. Reporting peaked in 2021 at $446 and has fallen 90.7% since, to $41 in 2025.
Across 14 payments — averaging $47.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optos, Inc.$182
- Alcon$142
- Eyevance Pharmaceuticals LLC$139
- Biotissue Holdings Inc.$80
- Bausch & Lomb Americas Inc.$42
- Rayner Intraocular Lenses Limited$22
- plus $54 from 3 others
What the payments were for
- Food & beverage$64197%
- Gifts$193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optos, Inc. | 1 | $182 |
| Alcon | 2 | $142 |
| Eyevance Pharmaceuticals LLC | 3 | $139 |
| Biotissue Holdings Inc. | 2 | $80 |
| Bausch & Lomb Americas Inc. | 2 | $42 |
| Rayner Intraocular Lenses Limited | 1 | $22 |
| Lombart Brothers, Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Johnson & Johnson Vision Care, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PANORAMIC OPHTHALMOSCOPE$364
- OCT OPHTHALMOSCOPE$182
- NFC-700$182
- Precision 1$125
- Tobradex ST$114
How this compares
$660 in reported general payments places this provider in the 55th percentile of 2,257 optometrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 12 | $9,914 |
| LumiganBimatoprost | 12 | $4,494 |
| Latanoprost | 100 | $1,188 |
| Prednisolone Acetate | 39 | $1,004 |
| Timolol Maleate | 51 | $608 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 32 | $414 |
| Acyclovir | 12 | $293 |
| Ofloxacin | 30 | $279 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 16 | $134 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Morris
- Pamela LoweChicago$447K
- Jeffrey LewisChampaign$394K
- Adeyinka AdewaleGodfrey$391K
- Michael ChaglasianChicago$367K
- Jessilin QuintChicago$366K
- Jullian CerasuoloChicago$329K
- Steven EidenDeerfield$259K
- Peter KehoeGalesburg$167K
- Gulroop HansraDowners Grove$151K
- Treacy AdamoHinsdale$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.